biote director granted 130,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
biote Corp. director Bret Christensen received a grant of stock options, giving him the right to buy 130,000 shares of Class A Common Stock. The options have an exercise price of $2.34 per share and expire on June 7, 2036.
All 130,000 option shares will vest on the earlier of June 8, 2027 or the day before biote Corp.'s 2027 Annual Meeting of Stockholders, as long as Christensen remains in continuous service through that vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 130,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. All shares subject to the option award shall vest on the earlier of June 8, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Class A Common Stock financial
Annual Meeting of Stockholders financial
continuous service financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did biote Corp. (BTMD) report for Bret Christensen?
How many biote Corp. (BTMD) options were granted to Bret Christensen?
What is the exercise price of Bret Christensen’s biote Corp. (BTMD) options?
When do Bret Christensen’s biote Corp. (BTMD) options vest?
When do Bret Christensen’s biote Corp. (BTMD) options expire?
Is Bret Christensen’s biote Corp. (BTMD) Form 4 transaction a market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.